Company / Operating Cash Flow
Cytosorbents Corp Operating Cash Flow History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$10.8M
FY2018
5-year range
-$10.8M / -$6.3M
FY2014-FY2018
Trend
-67.8%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$6M to -$11M over the past 2 years.
Based on SEC 10-K filings.
-$11M in FY2018.
Declined from -$6M to -$11M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, operating cash flow decreased 67.8% year-over-year.
- Peak operating cash flow was recorded in FY2013.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | -$10.8M | -67.8% |
| FY2017 | -$6.5M | -2.9% |
| FY2016 | -$6.3M | +30.6% |
| FY2015 | -$9.0M | -35.8% |
| FY2014 | -$6.7M | -84.2% |
| FY2013 | -$3.6M | +0.0% |
| FY2012 | -$3.6M | +5.5% |
| FY2011 | -$3.8M | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026